MO201ANALYSIS OF USAGE OF SODIUM ZIRCONIUM CYCLOSILICATE (SZC) AT HULL UNIVERSITY TEACHING HOSPITALS
Sign Up to like & getrecommendations! Published in 2021 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfab092.0079
Abstract: Renin Angiotensin Aldosterone System (RASS) inhibitor therapy is key to the management of several chronic long term conditions; however, RAAS inhibitors can cause hyperkalaemia and thus limiting its use. Sodium zirconium cyclosilicate, was approved in… read more here.
Keywords: treatment; serum potassium; range; potassium level ... See more keywords